Letaxaban

DB11984InvestigationalSmall molecule

Letaxaban has been used in trials studying the treatment and prevention of Venous Thromboembolism and Acute Coronary Syndrome.

Chemical structure of Letaxaban
Mechanism
Curator reviewed
Formula / weight
C22H26ClN3O5S · 479.977 g/mol (avg)
Code names
TAK-442

Resolves to

Compound
UNIIY3WB03966WCAS870262-90-1ChEMBLCHEMBL1095032PubChem11641515
Structure
InChIKeyGEHAEMCVKDPMKO-HXUWFJFHSA-NSMILESO[C@H](CS(=O)(=O)C1=CC=C2C=C(Cl)C=CC2=C1)C(=O)N1CCC(CC1)N1CCCNC1=O
Targets
P00742F10

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
642Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Letaxaban, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In